About Conference
The International Conference on Endocrinology, Diabetes and Metabolism explores advances in hormonal disorders, metabolic dysfunctions, diabetes care, and therapeutic innovations.
Highlights
Hormonal imbalance research, diabetes management, metabolic syndrome, insulin resistance, obesity links, thyroid disorders, endocrinology innovations, clinical trials, keynote talks, expert panels, pediatric endocrinology, and hormone therapy.
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
Primary Sjögren's syndrome patients' B-Cell Stimulating Factors are associated with the growth of lymphomas.
2.
Silibinin is a novel and ancient molecule that highlights the significance of integrated therapies for cancer.
3.
An inhibitor of JAK1 exhibits "remarkable" activity in T-cell lymphoma.
4.
Analysis of 2021 data shows new cancer diagnoses did not rebound as expected following pandemic
5.
New imaging guidelines for head and neck cancers, a step toward practice change
1.
The Statistical Evolution of Cancer Staging and Its Precision Impact on Prognosis and Therapy in Cancer Staging 2025
2.
The Importance of Understanding Your D-Dimer Levels: A Comprehensive Guide
3.
The Life-Saving Powers of Anemia: How to Combat the Disease.
4.
The Importance of Early Detection in Angiosarcoma: A Story of Survival
5.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Exploring the Hospitalization Burden in Refractory and Relapsed ALL
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
3.
Navigating the Complexities of Ph Negative ALL - Part X
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
5.
"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC
Recommended News For You
1.
AMA President-Elect Confronts a New Challenge: A Brain Tumor
2.
Weight loss and cancer; no brain tumor blood test; no cervical cancer after HPV vaccination.
3.
automated, precise reporting for clonality testing using NGS.
4.
In CML Patients With New Diagnoses, STAMP Inhibitor Outperforms Imatinib and Second-Gen TKIs.
5.
The American College of Physicians updated its recommendations for colorectal cancer screening.
Conferences That Might Interest You
Recommended Articles For You
1.
Exploring the Potential of Cytologic Atypia in Cancer Diagnosis
2.
Cancer Diagnosis in 2025: Innovations, Education, and Evolving Clinical Strategies
3.
Survivin as a Key Regulator in Gynecological Cancers: Therapeutic and Prognostic Implications
4.
What is Hemorrhagic Cystitis and How to Manage its Symptoms
5.
CAR T-Cell Therapy: Revolutionizing Hematologic Malignancies
Boost Your Knowledge With These Quizzes
1.
Quiz On Darier's Disease Management
2.
Quiz on Oncologic Emergencies: Recognition and Immediate Management of Acute Cancer-Related Complications
3.
Quiz On Pharyngitis Management
4.
Quiz On Pelvic Organ Prolapse (Pop)
5.
Incretin Mimetics: Navigating the GLP-1 and GIP Landscape in Type 2 Diabetes
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge